Past events
Neuroscience 2024
6th – 9th October 2024
Chris Mathes will be attending Neuroscience 2024. Contact Chris to arrange time to meet.
Poster: #14146 Identification of venom fractions as TREK-1 modulators using Qube 384 automated patch clamp system’.
ELRIG Drug Discovery
2nd – 3rd October 2024
Sophie Rose, Eddy Stevens, Federico Olivero, Sergiy Tokar, Zeki Ilkan and Alex Haworth will be attending ELRIG Drug Discovery ‘Connecting Minds, Transforming Science, Empowering the Community’.
Posters:
GLP hERG Assay Validation following ICH E14/S7B 2022 Q&A best practice guidelines
Using high-throughput automated patch clamp electrophysiology to identify novel TREK-1 modulators in an animal venom library
Scientifica PatchScope Pro: an integrated calcium-imaging and patch-clamp system suitable for selecting specific subsets of neurons for electrophysiological recordings
Fluorescence-based drug repurposing screen of the potassium channel, KV3.1 with V434L mutation
Safety Pharmacology Society Annual Meeting 2024
22nd – 25th September 2024
Sophie Rose, Steve Jenkinson and Chris Mathes are looking forward to seeing you at SPS.
Booth: 203.
Oral presentation: Steve will present ‘Safety evaluation of the Comprehensive In Vitro Proarrythmia Library to Assess Cardiotoxicity Potential Using the VOLTA Scanner’ in Lumencor’s sponsored session on 24th September at 2:30pm – 3:00pm.
Recent Progress Towards a Potential Treatment for KCNC1-related Disorders
18th September 2024
Webinar:
A (Parent’s) Duty to Hope, Stephanie Telesca, Co-founder of The KCNC1 Foundation
Models and mechanisms of KCNC1-related disorders, Ethan M. Goldberg, M.D., Ph.D., Associate Professor in the Division of Neurology at The Children’s Hospital of Philadelphia
How Metrion Biosciences helped identify a potential treatment for patients with the KCNC1 variant, Scott Maidment, Head of High Throughput Screening, Metrion Biosciences
Linköping Ion Channel Meeting
11th – 12th September 2024
Sophie Rose looks forward this meeting which will delve into electrophysiology with a focus on ion channels.
Science and Technology Solutions Exhibition
11th September 2024
This event is right on our doorstep as the marquee will be set-up at Granta Park, Cambridge, UK. Here you will find John Ridley and Zeki Ilkan at booth 32 so please drop by to discuss your drug discovery projects.
Sophion User Meeting – North America
21st – 22nd August 2024
Dr Steve Jenkinson looks forward to connecting with others utilising ground breaking automated patch-clamp technology.
BioWednesday London Summer Social
17th July 2024
Meet Zeki Ilkan, Commercial Operations Scientist, at the One Nucleus BioWednesday London Summer Social.
RICT 2024 – 58th International Conference on Medicinal Chemistry
3rd – 5th July 2024
Come and meet Dr Sophie Rose, Head of Business Development at the conference, who will look forward to meeting you and having topical discussions.
FENS Forum 2024
25th – 29th June 2024
Dr Tony Rush, Director of Neuroscience and Federico Olivero, Research Associate Scientist attended the FENS Forum which was held in Vienna, Austria for discussions on Neuroscience.
Federico presented the poster ‘Scientifica PatchScope Pro: An Integrated Calcium-Imaging and PatchClamp System Suitable for Selecting Specific Subsets of Neurons for Electrophysiological Recordings’ in poster session 06 on 28th June between 2pm – 3:30pm at Poster board PS06-28PM-442.
Sophion ICMS
19th – June 20th June 2024
Metrion attended the conference and held discussions about the science of ion channel modulation.
Babraham Showcase
Tuesday 11th June 2024
Metrion attended the Babraham Research Campus, we welcomed you to come and meet Dr. Sophie Rose in the Cambridge Building between 9:30am and 3:30pm to find out how we could support your ion channel, cardiac safety and neuroscience drug discovery projects.
Cure CLCN4 Scientific Conference 2024
7th – 8th June 2024
Metrion Biosciences attended the Cure CLCN4 Scientific Conference 2024 which took place in London 7th-8th June 2024. Dr Sophie Rose, Head of Business Development met many people there.
SLAS Europe 2024 Conference
May 27th – May 29th 2024
Meet Dr Sophie Rose, Head of Business Development and Dr Scott Maidment, Head of High Throughput Screening attended the SLAS Europe 2024 conference to discuss life sciences and biotechnology.
Scott presented the poster ‘Fluorescence-based drug repurposing screen of the potassium channel, KV3.1 with V434L mutation.
In Vitro Assessment of Cardiac Risk in Drug Discovery
May 16th 2024
Joining Derek Leishman, VP of Translational and Quantitative Toxicology at Eli Lilly and Company, who shared insights on leveraging non-clinical data in regulatory integrated QTc assessment.
Steve Jenkinson, VP of Drug Discovery and Safety at Metrion Biosciences, presented a clinically translatable hIPSC cardiomyocyte model to predict QTc and QRS cardiac risk.
The webinar was chaired by Eddy Stevens, CSO, Metrion Biosciences.
Cambridge Ion Channel Forum 2024
May 8th 2024
Metrion Biosciences and AstraZeneca co-organised the Cambridge Ion Channel Forum (CICF) which took place on the 8th May 2024.
The event took place at the DISC (The Discovery Centre, AstraZeneca) at the Cambridge Biomedical Campus at the Addenbrookes Hospital site. The event comprised of a networking lunch, a series of talks, a networking coffee break and a poster session plus a drinks and pizza reception to facilitate further networking opportunities.
HESI Workshop
May 7th – May 8th 2024
Steve Jenkinson, VP Drug Discovery and Safety Assessment USA at Metrion Biosciences, will be virtually attending this event and looks forward to hearing about, and contributing to discussions on, the use of cardiac NAMs, updates from the HESI U01 subaward validation studies, FDA perspectives, and the latest work of the HESI Cardiac Safety Committee.
LifeArc Translational Sciences Summit
April 23rd 2024
Meet Dr Sophie Rose, Head of Business Development, and Dr John Ridley, Director of Commercial Operations, at the LifeArc Translational Science Summit for discussions on how translational science can bridge the gap between basic research and clinical applications
ELRIG Research and Innovation 2024
March 20th – March 21st 2024
Metrion Biosciences is attending ELRIG Research and Innovation 2024 taking place in Manchester, UK.
Metrion’s Head of Business Development, Europe Dr. Sophie Rose will be attending the meeting and if you would like to meet with her, please email info@metrionbiosciences.com.
This event will discuss how emerging biology and cutting-edge technologies are pioneering the medicines of tomorrow. Bringing together scientists, researchers and entrepreneurs with bold ideas to serve our shared ambitions in creating the next generation of therapeutics to cure more patients around the world. The 2024 R&I meeting will focus on cutting edge innovation.
SOT 63rd Annual Meeting and ToxExpo 2024
March 10th – March 14th 2024
Metrion Biosciences is attending Society of Toxicology 2024 taking place on the 10th – 14th March 2024, in Utah, USA.
Metrion’s VP, Drug Discovery and Safety Assessment Dr. Steve Jenkinson will be attending the meeting and if you would like to meet with him, please email info@metrionbiosciences.com.
The three-day ToxExpo—taking place from 9:00 am to 4:30 pm, March 11–13, 2024—features companies and organizations that support toxicologists and the toxicology community. Exhibitors include research organizations, government agencies, laboratory suppliers, drug developers, consulting firms, and academic institutions.
Stop by to visit with these exhibitors between sessions, during lunch, or at other times throughout the day to learn about products and services, job opportunities, new technology, and more.
Sophion EU User Meeting 2024
March 7th – March 8th 2024
Metrion Biosciences is attending the Sophion Bioscience EU User Meeting 2024 taking place on the 7th – 8th March 2024 in Copenhagen, Denmark.
Dr Catherine Hodgson and Dr Tom Hill will be attending the meeting on behalf of Metrion.
Catherine will also be presenting at the meeting. Catherine’s presentation is entitled: ‘The dogma of Fluoride, are there alternatives to use on the Qube?’
If you would like to meet with Tom and Catherine at the event, please email info@metrionbiosciences.com.
Japanese Safety Pharmacology Society Annual Meeting
February 22nd – February 23rd 2024
Metrion Biosciences is attending the Japanese Safety Pharmacology Society Annual Meeting which is taking place on 22nd and 23rd February 2024. Metrion’s Scientists will be presenting a poster and will also have a booth at the event.
Two delegates from Metrion will be attending the meeting. If you would like to meet with them, please email info@metrionbiosciences.com.
The event will be held at Senri Life Science Center in Osaka.
Biophysical Society (BPS) Satellite Meeting
February 9th 2024
Metrion Biosciences will be attending the BPS Society Annual Satellite Meeting (BPS) 2024 taking place on the 9th February 2024, in Philadelphia, USA.
Ion channels are an important class of therapeutic drug targets, and mutations in ion channel genes are found to be responsible for an increasing number of diseases. While conventional electrophysiological techniques permit the most detailed and direct study of ion channel function, they are limited due to the manual nature of the method and their low throughput. Because of this, ion channels remain an underrepresented target class for drug discovery.
The advent of higher throughput automated electrophysiology systems changed the face of ion channel drug discovery. Since the inaugural “Drug Discovery for Ion Channels” satellite meeting, there have been many advances in ion channel drug discovery including new instrumentation and techniques. For this year, the Biophysical Society proposes to continue the “Satellite Meeting” tradition at the Biophysical Society Annual Meeting and review the advances ion channel drug discovery.
This year’s meeting will highlight presentations from drug discovery companies, companies that provide ion channel services to drug discovery companies and companies that provide products to ion channel drug discovery companies, as well as other speakers in the field of ion channel drug discovery, including several academic speakers.
SLAS 2024 International Conference and Exhibition
February 3rd – February 7th 2024
Metrion Biosciences is attending SLAS 2024 International Conference and Exhibition taking place on the 3rd – 7th February 2024, in Boston, USA. Metrion will be exhibiting at the event, at booth number 384.
Two delegates from Metrion, Scott Maidment, Head of High Throughput Screening and Sophie Rose, Head of Business Development, Europe will be attending the meeting and if you would like to meet with either Scott or Sophie, please email info@metrionbiosciences.com.
This year’s scientific program will encompass over 150 scientific talks spanning nine educational tracks within life sciences, technology and laboratory automation. Sessions will build off of the innovative, life-changing and sometimes surprising discoveries from over the last year.
SLAS 2024 will be hosted at Boston Conference, and Exhibition Center, Boston USA.
Pharma Integrates
November 16th
Metrion Biosciences’ Head of Business Development, Europe, Dr Sophie Rose is attending Pharma Integrates taking place on 16th November 2023, at the Mermaid in London.
Now in its twelfth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
This headline event for Life Science Integrates has become the must-attend event on the calendars of pharma and healthcare senior leadership.
A link to the agenda for 2023 can be found here: Pharma Integrates 2023 – Life Science Integrates
Neuroscience 2023
November 11th November 15th
Metrion Biosciences is attending Neuroscience 2023 taking place on the 11th – 15th November 2023, in Washington D.C. USA.
Metrion’s VP, Drug Discovery and Safety Assessment, Dr. Steve Jenkinson will be attending the meeting and if you would like to meet with him, please email info@metrionbiosciences.com.
Each year, scientists from around the world congregate to discover new ideas, share their research, and experience the best the field has to offer. Attend so you can: present research, network with scientists, attend session and events, and browse the exhibit hall.
Join the nearly half a million neuroscientists from around the world who have propelled their careers by presenting an abstract at an SfN annual meeting — the premier global neuroscience event.
Neuroscience 2023 will be hosted at the Walter E. Washington Convention Center in Washington D.C. USA.
Metrion Biosciences is attending Ion Channel Modulation Symposium – Japan taking place on the 2nd November 2023, in Japan.
Metrion’s Director, Screening Technologies Dr. Gary Clark will be attending the meeting and if you would like to meet with him, please email info@metrionbiosciences.com.
Dr. Gary Clark will be delivering a presentation on ‘Qube 384 – the Swiss army knife of patch-clamp electrophysiology’ if you would like to access more information about the presentation, please email info@metrionbiosciences.com.
Metrion Biosciences is attending ELRIG Drug Discovery 2023: Diverse Thinking – New Perspectives taking place on the 18th – 19th October 2023, in Liverpool UK.
Metrion’s Head of Business Development, Europe, Dr. Sophie Rose, Director of Commercial Operations, Dr. John Ridley, and Scientist Adam Young be attending the meeting if you would like to meet with them, please email info@metrionbiosciences.com.
Adam Young will be delivering a presentation during the Early Career Professional Flash Poster session at 13.00 – 13.50 in the Learning Zone.
ELRIG Drug Discovery 2023: Diverse Thinking – New Perspectives be hosted at The Exhibition Centre , ACC in Merseyside, Liverpool.
Metrion Biosciences are attending, and sponsoring the Sophion Ion Channel Modulation Symposium 2023 organised by Sophion Bioscience taking place at the University of California.
Metrion’s VP, Drug Discovery and Safety Assessment Steve Jenkinson will be attending the Symposium on behalf of the Company. If you would like to arrange a meeting with Steve please contact info@metrionbiosciences.com.
Sophion are excited to invite you to the Ion Channel Modulation Symposium at the University of California Irvine School of Medicine. The forthcoming meeting is a collaborative effort co-hosted by Sophion Bioscience and the University of California, Irvine (UCI) – School of Medicine. The symposium takes place on Wednesday and Thursday, October 18-19, 2023, at The Beckman Center, 100 Academy, Irvine, CA.
Keynote speaker Prof. Ardem Patapoutian – Scripps Research, Howard Hughes Medical Institute,
Dean’s Distinguished Lecture Series, Community Lecture, “The role of PIEZO ion channels in sensory biology”
Metrion Biosciences is attending Drug Safety Forum: Making Safety Part of Drug Design at the Cripps Court at the address 1-3 Chesterton Road, Cambridge, CB43AD taking place on the 12th October 2023, in Cambridge UK.
Metrion’s Head of Business Development, Europe, Dr. Sophie Rose be attending the meeting and if you would like to meet with her, please email info@metrionbiosciences.com.
This one day meeting will bring together experts in the field to consider different aspects of making safety an intrinsic part of drug design from target and chemical evaluation through to regulatory strategy. This one day meeting will bring together experts in the field to consider different aspects of making safety an intrinsic part of drug design from target and chemical evaluation through to regulatory strategy. We are planning a full programme of short talks. The day will run from 9am to 5pm with lunch and refreshments provided throughout the day. The meeting will be highly relevant for pharma and biotech industry\, academics and government scientists in the drug discovery and development field.
This meeting will be hosted at Cripps Court in Cambridge, UK.
Metrion Biosciences is attending Triangle Biotech Tuesday at the APE Pavilion at the address 21 Alexandria Way on the 10th October 2023, in Durham USA.
Metrion’s Director, Business Development, Dr. Angela Stoyanovitch will be attending the meeting and if you would like to meet with her, please email info@metrionbiosciences.com.
TBT is a monthly networking group for life-sciences, biotech, pharma, and biopharma professionals
HOW WE CAME TO BE: John Mayfield visited Boston in February 2012 and attended an event by the original Biotech Tuesday! He was extremely impressed with how many great conversations and new people he met. When he returned to Durham, he began searching for a similar event, but could not find one. The only answer was to bring Triangle Biotech Tuesday to the Research Triangle Park.
This meeting will be hosted at ARE Pavilion in Durham, USA.
Metrion Biosciences is attending Stem Cells & Applications for Drug Discovery at The Lab, 90 Regent Street, Cambridge, CB21DP taking place on the 6th October 2023, in Cambridge UK.
Metrion scientists will be attending the event and if you would like to meet with them, please email info@metrionbiosciences.com.
Throughout this evening event, we will cover a variety of fascinating topics related to stem cells and their applications in drug discovery.
Discussion topics include:
- Stem Cell Therapy: Discussing how stem cells are used in regenerative medicine and potential treatments.
- Drug Discovery Process: Understanding how stem cells play a crucial role in identifying and testing new drugs.
- Disease Modeling: Exploring how stem cells can be used to create disease models for research purposes.
- Ethical Considerations: Examining the ethical implications and challenges surrounding stem cell research.
This meeting will be hosted at The Lab in Cambridge, UK.
Metrion Biosciences is hosting a Company Showcase at the Cambridge Building on Babraham Research Campus taking place on the 5th October 2023, in Cambridge UK.
Dr. Sophie Rose, Metrion’s Head of Business Development, Europe will be attending the showcase. If you would like to meet with Sophie, please email info@metrionbiosciences.com.
The Company Showcase will be hosted at The Cambridge Building at Babraham Research Campus Cambridge, UK.
Metrion Biosciences is attending the 33rd Cambridge Neuroscience Seminar taking place on the 26th September 2023, in Cambridge UK.
Metrion’s Chief Scientific Office, Dr. Edward Stevens, and Director of Operations, Dr. John Ridley will be attending the meeting and if you would like to meet with them, please email info@metrionbiosciences.com.
This year, will be focused on dementia. Dementia research has made phenomenal advances over the last couple of decades, with many of the major discoveries made by researchers at Cambridge. There are more than 150 researchers working in dementia research across Cambridge in a range of Departments and across all of our themes. The research spans genetic, molecular and cellular models of neurodegeneration through to the characterisation of human pathophysiology of dementia, to early phase clinical trials. What will be highlight at this meeting is the strength in the interdisciplinary approach to tackling dementia and how collaboration with the communal aim of understanding these diseases and identifying new treatments is key. This meeting will be open to neuroscientists of every discipline and not just dementia scientists – posters will be presented on all of the six themes of Cambridge Neuroscience.
The 33rd Cambridge Neuroscience Seminar will be held at Robinson College in Cambridge, UK.
Metrion Biosciences is attending the Inaphaea Biolabs Launch supported by Bionow taking place on the 26th September 2023, at MediCity in Nottingham, UK.
Metrion’s Head of Business Development, Europe, Dr Sophie Rose will be attending the meeting and if you would like to meet with her, please email info@metrionbiosciences.com.
A summary of the event:
Inaphaea BioLabs & Bionow are inviting you to the Inaphea Lab Launch Event on Tuesday 26th September. During the day there will be talks from scientific experts, opportunities to network over coffee and lunch, and tours of the new laboratories. The tour will include the recently acquired assets from Imagen, which are currently being moved to the Inaphaea BioLabs facility in their Nottingham Labs at MediCity
The event will run from 12.00pm and will be held at MediCity, Nottingham.
Metrion Biosciences will be attending the conference: Safety Pharmacology Annual Meeting 2023 (SPS2023)
Metrion’s Dr. Sophie Rose, Dr. John Ridley, and Dr. Steve Jenkinson will be attending the event, and will be at booth number 207 if you would like to have a meeting with them or alternatively can arrange a meeting by contacting info@metrionbiosciences.com.
The Safety Pharmacology Society Annual Meeting is a must-attend event for anyone interested in the field of safety pharmacology. This conference brings together experts from around the world to share the latest research and knowledge on the evaluation of the safety of new drugs and chemicals. Attendees will have the opportunity to learn from renowned scientists, participate in educational sessions, and network with peers and leaders in the field. Whether you are a seasoned professional or a student just starting out, the Safety Pharmacology Society Annual Meeting is an excellent opportunity to expand your knowledge and enhance your career in the field of safety pharmacology.
Attending a meeting in Brussels is a fantastic opportunity to connect with professionals from around the world in one of Europe’s most vibrant cities. With a thriving pharmaceutical industry and regulatory environment, Brussels is the perfect location to learn about the latest trends and innovations in your field, and to network with like-minded professionals. In addition to the inspiring surroundings and excellent opportunities for professional development, the city offers plenty of history, culture, and gastronomy to explore. Whether you’re a seasoned professional or a student just starting out, attending a meeting in Brussels is an experience you won’t want to miss.
Metrion Biosciences is attending the 2nd International Kv7 Channels Symposium taking place on the 13th – 15th September 2023, in Naples Italy.
Metrion’s Head of Business Development, Europe, Dr. Sophie Rose will be attending the meeting and if you would like to meet with her, please email info@metrionbiosciences.com.
This symposium will showcase the myriad aspects of Kv7 research, with emphasis on emerging research areas. Contributions from leading academics and pharmaceutical company representatives will provide a programme that will stimulate all attendees irrespective of their interest in these fascinating and enigmatic channels.
The 2nd International Kv7 Channels Symposium will again be hosted at the University of Naples Federico II in the beautiful surroundings of the bay of Naples, Italy.
Metrion Biosciences is attending the SCI / RSC 22nd Medicinal Chemistry Symposium taking place on the 10th – 13th September 2023, in Cambridge, UK.
Metrion will have a delegate attending the meeting and if you would like to meet with them, please email info@metrionbiosciences.com.
Metrion are delighted to be attending the 22nd SCI-RSC Medicinal Chemistry symposium, Europe’s premier biennial Medicinal Chemistry event, focusing on first disclosures and new strategies in Medicinal Chemistry.
The exhibition will run alongside the conference during refreshment breaks and poster sessions. Those who wish to exhibit are encouraged to book early to avoid disappointment. Exhibition stands will be available to book via the registration page when registration opens, and the rate will include two stand staff and daytime refreshments.
SCI / RSC 22nd Medicinal Chemistry Symposium will be hosted at Churchill College in Cambridge, UK.
Metrion Biosciences is attending the BioWednesday Stevenage – Road to Success: Navigating the Innovation Pipeline in Therapeutics Meeting 2023 taking place on the 6th September 2023, in Stevenage, UK.
Metrion will have a delegate attending the meeting and if you would like to meet with them, please email info@metrionbiosciences.com.
BioWednesday Stevenage: Road to Success – Navigating the Innovation Pipeline in Therapeutics Meeting 2023 will be hosted at Stevenage BioScience Catalyst Gunnels Wood Road Stevenage
Metrion Biosciences is attending RICT 2023 (57th International Conference on Medicinal Chemistry) taking place on the 5th – 7th July 2023, in Lille, France.
Metrion will have a delegate attending the meeting and if you would like to meet with them, please email info@metrionbiosciences.com.
The congress will be devoted to “Drug Discovery and Selection” and the main topics will be:
- Next Generation of Anti-infective Agents
- Neurodegenerative diseases
- Small Molecules for Immuno-oncology or Autoimmunity
- New Avenues in Drug Discovery Chemistry
- New Molecular Landscapes in Drug Discovery
- Case studies in Selected Therapeutic Areas
- Late-Breaking Topics: First Disclosures of Clinical Candidates
RICT 2023 will be hosted at the rue Michel de Ghelderode 33/02 – BE B-1348 Louvain-la-Neuve.
Metrion Biosciences is attending the 19th World Congress of Basic & Clinical Pharmacology (WCP2023) taking place on the 2nd – 7th July 2023, in Glasgow, Scotland.
Metrion will have a booth at the event and two delegates attending the meeting and if you would like to meet with them, please email info@metrionbiosciences.com.
This conference will welcome the world’s pharmacology and therapeutics community to the Scottish Events Campus. WCP look forward to celebrating the diversity of this community, from students and early career pharmacologists to the world’s leading authorities; from clinical pharmacologists working in national healthcare systems to innovators at the cutting edge of drug discovery in industry and academia.
The 19th World Congress of Basic & Clinical Pharmacology 2023 will be hosted at the Scottish Events Campus (SEC) in Glasgow, Scotland.
Metrion Biosciences is attending the Sophion ICMS 2023 taking place on the 21st and 22nd June 2023, at Clare College in Cambridge.
Metrion will have 4 delegates attending the meeting and if you would like to meet with them, please email info@metrionbiosciences.com. Metrion will also have an exhibition booth at the event and will update this page with the booth number as soon as this has been confirmed.
Sophions’ Ion Channel Modulation Symposium (ICMS) aims to provide a valuable platform to bring together leading ion channel researchers from academia and drug discovery to stimulate discussion, develop collaborations, and sharing the latest advances and cutting edge research of this important class of receptors.
Invited speakers will address a spectrum of ion channel topics, such as, new therapeutic targets, advances in the understanding of ion channel protein structures, advances in techniques for the study of ion channels and ‘traditional’ ion channel targets such as pain, inflammation, cardiovascular and neurological. The meeting aims to cover a broad range of ion channels and to present issues that are important in their modulation for the purpose of drug discovery and to look at innovative technologies and approaches to this research.
Metrion Biosciences is attending the Cure CLCN4 Scientific Conference 2023 taking place on the 16th – 17th June 2023, in London.
Metrion’s Sales and Marketing Manager, Dr Sophie Rose will be attending the meeting and if you would like to meet with her, please email info@metrionbiosciences.com. Sophie will also be attending the conference dinner on the evening of 16th June.
For the second year in a row, this conference will bring together leading academic, clinical and industry speakers from the ion channel, rare disease, and therapeutic discovery fields. Through a series of short talks and panel discussions, we will review the latest knowledge on the biology and clinical aspects of CLCN4-NDC and establish the necessary steps towards the development of therapeutic options for CLCN4, all the way from the early stages of basic research on animal and cellular models to clinical research, drug discovery, and precision medicine.
Metrion Biosciences is attending the RSC Anglo-Nordic Medicinal Chemistry Symposium 2023 taking place on the 13th – 16th June 2023, in Denmark.
Metrions’ Commercial Operations Scientist, Claire Piochon will be attending the meeting and if you would like to meet her, please email info@metrionbiosciences.com.
This 2.5 day symposium is the third in the very successful series of biannual meetings started in 2017 containing high quality international speakers from industry and academia on topics of Medicinal Chemistry and related enabling technologies. Organised by the Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry, together with Nordic affiliates, the meeting promises to be an exciting and invigorating gathering packed with fantastic opportunities to disseminate knowledge and expand networks.
Metrion Biosciences and AstraZeneca are co-organising the Cambridge Ion Channel Forum (CICF) taking place on Wednesday 10th May 2023.
The event will take place at the Cambridge Building at the Babraham Research Campus Conference Centre in Cambridge. The event will comprise a networking lunch, a series of talks, a networking coffee break and a poster session plus a drinks reception.
Metrion Biosciences is attending the 34th Medicinal Chemistry in Eastern England conference, taking place on 27th April 2023 at the Fielder Centre in Hatfield, UK.
Metrion’s Sales and Marketing Manager, Dr Sophie Rose will be attending the meeting and if you would like to meet with themher, please email info@metrionbiosciences.com.
Known colloquially as the “Hatfield MedChem” meeting, this is a highly successful, long-standing, one-day meeting that runs annually. The scientific program will comprise presentations showcasing medicinal chemistry case studies from tools to candidates, across a range of modalities, therapeutic areas and target classes, as well as covering more general topics at the forefront of drug discovery. The meeting aims to be informal and interactive, and is ideal for all those working in medicinal chemistry and drug discovery more widely.
Metrion Biosciences are attending Empowering Women in Biotech, taking place on 18th April 2023 at Charnwood Molecular in Loughborough, UK.
Metrion’s Sales and Marketing Manager, Dr. Sophie Rose will be attending the meeting and if you would like to meet with her, please email info@metrionbiosciences.com.
Share personal and professional experiences and career strategies from a woman’s perspective
Help women, wherever they are in the career paths, realise their future goals.
Encourage women to enter and maintain careers in Biotech.
Generate a wider network of professionals working in Biotech
An all inclusive event where all are welcome especially:
-Women in academia and industry who would like to network
-Women who would like to learn about and explore the opportunities available to them
Metrion Biosciences are attending the Research and Innovation 2023 Conference, taking place on 29th and 30th March 2023 at the Wellcome Genome Campus, Cambridge.
Metrion will have a delegate attending the meeting and if you would like to meet with them, please email info@metrionbiosciences.com.
The 2023 ELRIG Research & Innovation conference will discuss how emerging biology and cutting-edge technologies are pioneering the medicines of tomorrow. Bringing together scientists, researchers and entrepreneurs with bold ideas to serve our shared ambitions in creating the next generation of therapeutics to cure more patients around the world. The 2023 R&I meeting will focus on cutting edge innovation, comprising the following four main sessions:
1 – Synthetic biology
2 – Healthy ageing
3 – AI driven drug discovery
4 – Ultra-rare disease drug discovery and personalized therapies
Metrion Biosciences is sponsoring and attending the 7th RSC-BMCS / SCI Symposium on Ion Channels as Therapeutic Targets, taking place on 27th and 28th March 2023 at the Wellcome Genome Campus, Hinxton, Cambridge.
Metrion’s Dr Alexandra Pinggera will be presenting at this meeting and if you would to meet with her please email info@metrionbiosciences.com.
Metrion will have a booth at the event and we would be delighted if you would stop by to say hello to our Chief Commercial Officer, Nick Foster and Sales and Marketing Manager, Sophie Rose.
Summary: Ion channels are important targets for therapeutic intervention due to their extensive roles in human physiology and the pathophysiology of disease. Many successful drugs targeting this gene family have been discovered for diseases such as hypertension, epilepsy and neuropathic pain.
This symposium, the 7th in an ongoing series, will showcase the most recent advances to aid the design of new ion channel therapeutics and promote interaction between scientists with a shared interest in the field of ion channel drug discovery.
Metrion Biosciences is attending the SOT 62nd Annual Meeting and ToxExpo, taking place on 19th – 23rd March 2023 at The Nashville Music City Centre.
Metrion’s Chief Commercial Officer, Nick Foster and Senior Scientist II, Ray Tang will be attending this meeting and will be at Booth number 1545. If you would to meet with Nick and Ray, please email info@metrionbiosciences.com.
Summary: More than 70 Featured and Scientific Sessions will take place in a friendly, relaxed atmosphere alongside 2,000+ poster presentations and the three-day ToxExpo featuring 250 companies.
Metrion Biosciences is sponsoring and attending the 2023 Biophysical Society Annual Meeting taking place at the San Diego Convention Center, 111 W Harbor Dr, San Diego, CA 92101, USA from 18th to 22nd February 2023.
Metrion’s Dr. Gary Clark and Dr. Nicola Secomandi will be attending the meeting. If you would like to meet with them, please email info@metrionbiosciences.com. Metrion will have a booth at the event, number 203. Please stop by to discuss your requirements with Gary and Nicola.
Metrion will also be sponsoring the ‘Drug Discovery for Ion Channels XXIII’ Satellite meeting taking place on Friday 17th February 2023 in Room 8 at the San Diego Convention Center.
The Biophysical Society annual meetings are the largest annual gathering of biophysicists around the world. The meetings include symposia, workshops, 15 subgroup programs, over 500 platform speakers selected from submitted abstracts, the Biophysical Society Lecture, more than 4,000 packed poster presentations, as well as educational exhibits, exhibitor presentations, and career development sessions.
Metrion Biosciences’ Chief Commercial Officer, Nick Foster, and Head of Operations, Dr. Robert Kirby, will be attending the 2023 Japanese Safety Pharmacology Annual Meeting taking place at the Yayoi Auditorium, The University of Tokyo, Ichijo Hall from 17th to 18th February 2023.
If you would like to arrange a meeting with either Nick or Rob, please email info@metrionbiosciences.com.
The Japanese Safety Pharmacology annual meeting will include multiple symposiums, lectures, workshops, poster presentations, and an excellent presentation award ceremony.
Upcoming events
Metrion Biosciences holds and participates in numerous events each year for professional development, knowledge sharing, self-improvement and networking opportunities. You will find a list of all our upcoming events here, please follow the links to find out more information about any of them.
Let’s work together
What are your specific ion channel and assay needs?
If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.